Recent News

• 10.18.2025 - Discussion of Clinical Data Presented at 2025 ESMO Congress, Including First Clinical Data from KO-2806, Kura’s Next-Generation FTI
• 10.18.2025 - Discussion of Clinical Data Presented at 2025 ESMO Congress, Including First Clinical Data from KO-2806, Kura’s Next-Generation FTI
• 09.16.2025 - FTI Preclinical Program Review
• 09.16.2025 - FTI Preclinical Program Review
• 09.16.2025 - Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types
• 09.16.2025 - Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types
• 09.16.2025 - Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types
• 09.10.2025 - Morgan Stanley Annual Global Healthcare Conference
• 09.10.2025 - Morgan Stanley Annual Global Healthcare Conference
• 09.10.2025 - Morgan Stanley Annual Global Healthcare Conference

Recent Filings

• 09.09.2025 - 4 Statement of changes in beneficial ownership of securities